News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
73–108
Matches
590
Sources here
21
Companies here
14
Search results Stored financial headlines

Active search

590 matching headlines

Ticker or company: SQUMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

How Investors Are Reacting To Intercontinental Exchange (ICE) Pershing Stake And Bond Issuance Momentum

In August 2026, Intercontinental Exchange, Inc. completed several fixed-income offerings totaling about US$3.73 billion in callable senior unsecured and subordinated notes with fixed coupons, alongside reporting strong July trading volumes and open interest across key asset classes. The disclosure that Pershing Square has built …

PS main company
Sharemaestro market context Stored weekly price path 16 weeks +7.5% · Next-week setup negative 33.8% PS stored weekly price path from 1 May 2026 to 14 Aug 2026

Is the Reported $400 Billion AstraZeneca-Bristol Myers Squibb Megamerger a Slam Dunk -- or a Disaster Waiting to Happen?

Key Points Earlier this month, AstraZeneca and Bristol Myers Squibb became the subject of merger rumors. Investors reacted negatively to the rumors, even if on paper such a deal would create an oncology-focused big pharma powerhouse worth around $400 billion. Considering regulatory uncertainty and …

BMY main company BMY main company BMY main company BMYS main company BRM main company
Sharemaestro market context Trend signal active 52 weeks +58.2% · Next-week setup positive 55.1% BMY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Barclays PLC discloses 1,837,155-share MSGE stake in Madison Square Garden Entert (MSGE)

Barclays PLC has filed an amended Schedule 13G, disclosing a beneficial ownership of 1,837,155 shares in Madison Square Garden Entertainment Corp. (MSGE), which represents 4.54% of the class. The filing specifies that Barclays PLC holds sole voting and dispositive power over 1,815,732 shares, and …

MSGE main company
Sharemaestro market context Trend signal active 52 weeks +117.2% · Next-week setup positive 63.2% MSGE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Madison Square Garden Sports Submits 10-K for Fiscal 2026 Detailing Potential Rangers and Knicks Spin-Off

Madison Square Garden Sports Corp. filed its Annual Report on Form 10-K for the fiscal year ending June 30, 2026, outlining plans for a potential spin-off to separate the New York Rangers and New York Knicks into two independent publicly traded companies. The board …

MSGS main company
Sharemaestro market context Trend signal active 52 weeks +105.0% · Next-week setup positive 56.2% MSGS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

U.S. FDA Grants Accelerated Approval to Bristol Myers Squibb's First CELMoD Therapy ZENBEXUS™, in Combination with Daratumumab and Hyaluronidase-fihj and Dexamethasone (ZDd) for Patients with Multiple Myeloma, as Early as First Relapse

Bristol Myers Squibb announced that the U.S. FDA has granted accelerated approval for ZENBEXUS™ (iberdomide) in combination with daratumumab and hyaluronidase-fihj and dexamethasone (ZDd) for adult patients with multiple myeloma who have received at least one prior line of therapy. This approval, based on …

BMY main company BMY main company BMY main company BMYS main company BRM main company
Sharemaestro market context Trend signal active 52 weeks +58.2% · Next-week setup positive 55.1% BMY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Z Squared Inc. 2Q 2026: Revenue $1.58M, Net loss $13.72M, EPS ($0.28) — 10-Q Summary

Z Squared Inc. (ZSQR) reported its second-quarter 2026 results, showing $1.58 million in revenue and a net loss of $13.72 million, resulting in a loss per share of $0.28. This performance follows the company's recent launch of crypto-mining operations and a strategic pivot from …

ZSQR main company
Sharemaestro market context Price below Trend Line 52 weeks -70.7% · Next-week setup negative 40.3% ZSQR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

US FDA approves Bristol Myers' blood cancer treatment

The U.S. FDA has approved Bristol Myers Squibb's combination treatment, iberdomide, for patients with a rare form of blood cancer called multiple myeloma. This treatment is intended for patients whose illness has relapsed or not responded to other therapies. Iberdomide works by targeting the …

BMY main company
Sharemaestro market context Trend signal active 52 weeks +38.1% BMY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Pharmacy giant Bristol Myers Squibb to build $2.3B Houston factory

Bristol Myers Squibb has chosen Houston, Texas, as the location for its new state-of-the-art manufacturing facility. This 60,000-square-foot site represents a $2.3 billion investment and is projected to create 500 skilled jobs in Generation Park. Construction is set to begin next year, with the …

BMY main company
Sharemaestro market context Trend signal active 52 weeks +38.1% BMY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Madison Square Garden (NYSE:MSGS) Posts Quarterly Earnings Results, Beats Estimates By $0.52 EPS

Madison Square Garden (MSGS) came out with quarterly earnings of $1.19 per share, beating the Zacks Consensus Estimate of $0.72 per share. This compares to a loss of $0.07 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report …

MSGS main company
Sharemaestro market context Trend signal active 52 weeks +105.0% · Next-week setup positive 56.2% MSGS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Madison Square Garden Entertainment (MSGE) Following Earnings Beat Faces A Fuller Valuation Debate

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Madison Square Garden Entertainment (MSGE) drew fresh investor attention after reporting fourth quarter and full year 2026 results that exceeded consensus estimates on …

MSGE main company
Sharemaestro market context Trend signal active 52 weeks +117.2% · Next-week setup positive 63.2% MSGE stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Appeals court revived a $6.7 billion lawsuit against Bristol Myers Squibb over delayed drug approvals

A federal appeals court has reinstated a $6.7 billion lawsuit against Bristol Myers Squibb, brought by UMB Bank on behalf of former Celgene shareholders. The suit alleges Bristol Myers deliberately delayed FDA approvals for three drugs, including the cancer therapy Breyanzi, to avoid payouts …

BMY main company
Sharemaestro market context Trend signal active 52 weeks +38.1% BMY stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Transcript : Pershing Square Holdings, Ltd., Q2 2026 Earnings Call, Aug 13, 2026

Pershing Square (LON:PSH) held its first earnings call as Pershing Square Inc., with Chief Executive Officer and Chairman Bill Ackman outlining a strategy centered on long-term compounding in its existing investment vehicles, potential new fund launches and efforts to improve trading in Pershing Square …

PSH main company
Sharemaestro market context Price below Trend Line 52 weeks -8.2% PSH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Swissquote Gets Mugged by Crypto Winter

Swissquote Gets Mugged by Crypto Winter - Moby THE GIST Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here. Swissquote is still pulling …

SQN main company
Sharemaestro market context Price below Trend Line 52 weeks -27.7% SQN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Earnings call transcript: Pershing Square Q2 2026 gains on AUM growth and stock rise

Pershing Square (LON:PSH) held its first earnings call as Pershing Square Inc., with Chief Executive Officer and Chairman Bill Ackman outlining a strategy centered on long-term compounding in its existing investment vehicles, potential new fund launches and efforts to improve trading in Pershing Square …

PS main company
Sharemaestro market context Stored weekly price path 16 weeks +7.5% · Next-week setup negative 33.8% PS stored weekly price path from 1 May 2026 to 14 Aug 2026

Pershing Square H1 Earnings Call Highlights

Pershing Square (LON:PSH) held its first earnings call as Pershing Square Inc., with Chief Executive Officer and Chairman Bill Ackman outlining a strategy centered on long-term compounding in its existing investment vehicles, potential new fund launches and efforts to improve trading in Pershing Square …

PS main company
Sharemaestro market context Stored weekly price path 16 weeks +7.5% · Next-week setup negative 33.8% PS stored weekly price path from 1 May 2026 to 14 Aug 2026

Should You Stay Invested in Block Stock After Its Q2 Earnings Beat?

Block, Inc. XYZ has entered the second half of 2026 with stronger operating momentum, improving profitability and several growth initiatives across Cash App and Square. The fintech company is also putting more focus on connecting its consumer and merchant ecosystems, while investments in artificial …

SQU main company
Sharemaestro market context Trend signal active 52 weeks +6.5% SQU stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Madison Square Garden Entertainment (MSGE) Stock May Be Fully Priced After Record Revenue

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Madison Square Garden Entertainment has delivered a very strong share price run over the past three years, while the latest valuation checks suggest the …

MSGS main company MSGE main company
Sharemaestro market context Trend signal active 52 weeks +105.0% · Next-week setup positive 56.2% MSGS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

GameSquare appoints Tom Wild as VP of creative strategy, EMEA

GameSquare Holdings has appointed Tom Wild as Vice President of Creative Strategy for the EMEA region, based in London. Wild brings 14 years of agency and marketing experience from WPP, Publicis, and Omnicom, and will report to Paul Ioakim, Head of Agency. This appointment …

GAME main company
Sharemaestro market context Price above Trend Line 52 weeks -52.7% · Next-week setup negative 41.7% GAME stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Why (TSQ) Price Action Is Critical for Tactical Trading

This article analyzes Townsquare Media Inc. Class A (NYSE: TSQ), highlighting a weak near and mid-term sentiment despite a positive long-term outlook. It details an exceptional risk-reward short setup and provides three AI-generated trading strategies (Position, Momentum Breakout, and Risk Hedging) with specific entry, …

TSQ main company
Sharemaestro market context Price below Trend Line 52 weeks -9.6% TSQ stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Bill Ackman's Pershing Square buys Netflix, 5 other stocks in 2026

Bill Ackman's Pershing Square Inc. disclosed on Wednesday that it had taken a new position in Netflix stock, returning to the streaming company after a loss-making investment in 2022, and added five other new positions in the first half of 2026. As of June …

PS main company
Sharemaestro market context Stored weekly price path 16 weeks +7.5% · Next-week setup negative 33.8% PS stored weekly price path from 1 May 2026 to 14 Aug 2026

GameSquare appoints agency veteran with about 14 years’ experience

GameSquare Holdings Inc. has appointed Tom Wild as Vice President of Creative Strategy for EMEA, a move aimed at expanding the company's agency platform and creative capabilities in international markets. Wild brings 14 years of experience from WPP, Publicis, and Omnicom, most recently leading …

GAME main company
Sharemaestro market context Price above Trend Line 52 weeks -52.7% · Next-week setup negative 41.7% GAME stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context